Correlation Between Entravision Communications and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entravision Communications and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entravision Communications and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entravision Communications and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Entravision Communications and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entravision Communications with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entravision Communications and Regeneron Pharmaceuticals.
Diversification Opportunities for Entravision Communications and Regeneron Pharmaceuticals
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Entravision and Regeneron is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Entravision Communications and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Entravision Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entravision Communications are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Entravision Communications i.e., Entravision Communications and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entravision Communications and Regeneron Pharmaceuticals
Considering the 90-day investment horizon Entravision Communications is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Entravision Communications is 3.02 times more volatile than Regeneron Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest 71,815 in Regeneron Pharmaceuticals on November 4, 2024 and sell it today you would lose (4,517) from holding Regeneron Pharmaceuticals or give up 6.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entravision Communications vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Entravision Communications |
| Regeneron Pharmaceuticals |
Entravision Communications and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entravision Communications and Regeneron Pharmaceuticals
The main advantage of trading using opposite Entravision Communications and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entravision Communications position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Entravision Communications vs. Marchex | Entravision Communications vs. Direct Digital Holdings | Entravision Communications vs. Cimpress NV | Entravision Communications vs. Townsquare Media |
| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |